Cargando…

Highly specific chimeric DNA-RNA-guided genome editing with enhanced CRISPR-Cas12a system

The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas12a system is composed of a Cas12a effector that acts as a DNA-cleaving endonuclease and a crispr RNA (crRNA) that guides the effector to the target DNA. It is considered a key molecule for inducing target-specific gene editin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hanseop, Lee, Wi-jae, Kim, Chan Hyoung, Oh, Yeounsun, Gwon, Lee Wha, Lee, Hyomin, Song, Woojeung, Hur, Junho K., Lim, Kyung-Seob, Jeong, Kang Jin, Nam, Ki-Hoan, Won, Young-Suk, Lee, Kyeong-Ryoon, Lee, Youngjeon, Kim, Young-Hyun, Huh, Jae-Won, Jun, Bong-Hyun, Lee, Dong-Seok, Lee, Seung Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035383/
https://www.ncbi.nlm.nih.gov/pubmed/35505967
http://dx.doi.org/10.1016/j.omtn.2022.03.021
Descripción
Sumario:The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas12a system is composed of a Cas12a effector that acts as a DNA-cleaving endonuclease and a crispr RNA (crRNA) that guides the effector to the target DNA. It is considered a key molecule for inducing target-specific gene editing in various living systems. Here, we improved the efficiency and specificity of the CRISPR-Cas12a system through protein and crRNA engineering. In particular, to optimize the CRISPR-Cas12a system at the molecular level, we used a chimeric DNA-RNA guide chemically similar to crRNA to maximize target sequence specificity. Compared with the wild-type (wt)-Cas12a system, when using enhanced Cas12a system (en-Cas12a), the efficiency and target specificity improved on average by 2.58 and 2.77 times, respectively. In our study, when the chimeric DNA-RNA-guided en-Cas12a effector was used, the gene-editing efficiency and accuracy were simultaneously increased. These findings could contribute to highly accurate genome editing, such as human gene therapy, in the near future.